Skip to main content

PRF Technologies Ltd.

PRFX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001801834

No open-market purchases or sales by PRF Technologies Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $280.6K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +4 vs. previous quarter
8
13F valueReported value at the end of Q2 2026
$280.6K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding PRFX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PRFX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by PRF Technologies Ltd. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by PRF Technologies Ltd. insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in PRF Technologies Ltd. at the end of Q2 2026; share changes are against Q1 2026.

See all 8 holders
Institutions holding PRFX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Yorkville Advisors Global, LP81,103$111.9K0.13%+81,103New
Jane Street Group, LLC80,387$110.9K0.00%+80,387New
Citadel Advisors LLC28,575$39.4K0.00%+15,355+116.1%Added
UBS Group AG10,415$14.4K0.00%+9,546+1,098.5%Added
Morgan Stanley2,783$3.84K0.00%+1,172+72.7%Added
Advisor Group Holdings, Inc.40$530.00%00.0%Unchanged
Rockefeller Capital Management L.P.1$10.00%+1New
Royal Bank of Canada233$00.00%+233New